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ABSTRACT
Natural antisense transcripts are at least partially
complementary to their sense transcripts. Cis-
Sense/Antisense pairs (cis-SAs) have been exten-
sively characterized and known to play diverse
regulatory roles, whereas trans-Sense/Antisense
pairs (trans-SAs) in animals are poorly studied.
We identified long trans-SAs in human and nine
other animals, using ESTs to increase coverage
significantly over previous studies. The percentage
of transcriptional units (TUs) involved in trans-SAs
among all TUs was as high as 4.13%. Particularly
2896 human TUs (or 2.89% of all human TUs) were
involved in 3327 trans-SAs. Sequence complemen-
tarities over multiple segments with predicted RNA
hybridization indicated that some trans-SAs might
have sophisticated RNA–RNA pairing patterns.
One-fourth of human trans-SAs involved noncoding
TUs, suggesting that many noncoding RNAs may
function by a trans-acting antisense mechanism.
TUs in trans-SAs were statistically significantly
enriched in nucleic acid binding, ion/protein binding
and transport and signal transduction functions and
pathways; a significant number of human trans-SAs
showed concordant or reciprocal expression pat-
tern; a significant number of human trans-SAs
were conserved in mouse. This evidence suggests
important regulatory functions of trans-SAs. In 30
cases, trans-SAs were related to cis-SAs through
paralogues, suggesting a possible mechanism for
the origin of trans-SAs. All trans-SAs are available
at http://trans.cbi.pku.edu.cn/.
INTRODUCTION
Natural antisense transcripts are at least partially comple-
mentary to their endogenous sense RNAs. Transcripts in
a cis-sense/antisense (cis-SA) pair are transcribed from the
opposite strands at the same genomic locus and thus dis-
play perfect RNA–RNA sequence complementarity,
whereas transcripts from a trans-sense/antisense (trans-
SA) pair are transcribed from diﬀerent genomic loci
and may have imperfect sequence complementarity (1).
Cis-antisense transcripts have been extensively studied
both computationally (2–5) and experimentally, and
found to play a variety of regulatory roles including invol-
vement in imprinting (6), alternative splicing (7) and
transcriptional interference (8). Studies of trans-antisense
RNAs (also termed trans-encoded RNAs or trans-acting
RNAs) have mainly focused on small RNAs such as small
interfering RNAs (siRNAs) and microRNAs (miRNAs)
which function in a trans base-pairing mechanism with
their targets and play important regulatory roles such as
in mRNA degradation and translational repression (9).
There is evidence suggesting that long trans-antisense
RNAs may also perform versatile regulatory functions
(10). In bacteria, there are several examples of functional
long trans- antisense transcripts (11–13). In eukaryotes,
to date in only three cases has the activity of long trans-
antisense been experimentally characterized: Lymnaea
anti-NOS prevents the translation of the nNOS protein
from its encoding mRNA, resulting in substantial suppres-
sion of nNOS enzyme activity (14,15); variant d of mouse
Msh4 forms double-stranded RNA (dsRNA) with Hspa5,
possibly inducing Hspa5 RNA degradation and resulting
in cell death (16); MBP’s antisense RNA reduces the
expression of the MBP gene, either by inhibition of
MBP transport from the nucleus or by selective
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myelin-deﬁcient mutant mice (17).
Three groups have used computational methods to
identify long trans-SAs from mRNAs and full-length
cDNAs in human and Arabidopsis: Lehner et al. identiﬁed
92 putative trans-SA transcript pairs in human mRNA
sequences (18); Li et al. identiﬁed 161 trans-SA transcript
pairs in human RefSeq mRNAs (10) and Wang et al.
identiﬁed 1320 trans-SA transcript pairs in Arabidopsis
from full-length cDNA sequences (19). Studies on long
trans-SAs are far from complete, especially given that
these analyses have not utilized the more extensively
available EST sequences. Therefore, the prevalence of
trans-SAs together with other features has not been eluci-
dated. Moreover, there have been no studies in animal
species other than human.
A number of long noncoding RNAs were found to
function as cis-antisense transcripts to regulate their over-
lapping sense genes (20,21). It was recently reported that
around 98% of all transcripts in human were likely to be
noncoding RNAs (22). The functions of most long non-
coding RNAs remain unknown. It is important to explore
whether they may function through trans-acting RNA–
RNA interaction.
The goal of our present work was to: (i) estimate the
prevalence of trans-SAs in diﬀerent animals; (ii) classify
the pairing and overlapping patterns of trans-SAs that
may correspond to diﬀerent regulatory mechanisms;
(iii) investigate how many long noncoding RNAs might
function by means of trans- RNA–RNA interaction in
RNA-mediated gene regulation; (iv) determine in what
biological events TUs in trans-SAs were most often
involved; (v) study whether some, if not all, of trans-SAs
may have correlated expression proﬁles; (vi) ﬁnd trans-
SAs that were conserved between diﬀerent species and
(vii) investigate how trans-SA originated by analyzing
the relationship between trans-SAs and cis-SAs.
MATERIALS AND METHODS
Identification of trans-SAs
We identiﬁed trans-SAs in human and nine other animal
species: Mus musculus (mouse), Rattus norvegicus (rat),
Bos taurus (cattle), Canis lupus familiaris (dog), Gallus
gallus (chicken), Danio rerio (zebraﬁsh), Drosophila
melanogaster (ﬂy), Caenorhabditis elegans (worm) and
Ciona intestinalis (sea squirt). These species were chosen
because they allowed a range of cross-species comparisons
with human and had relatively complete genomic
sequences and abundant ESTs.
Lessons from previous studies of cis-SAs indicated
that more SAs could be identiﬁed using ESTs in addition
to mRNAs, rather than mRNAs alone (4,5). Using ESTs,
however, is computationally more challenging
because there are an-order-of-magnitude more ESTs
than mRNAs and ESTs tend to have lower quality than
mRNAs. Identifying trans-SAs is also more challenging
than identifying cis-SAs because trans-SAs are transcribed
from separate genomic loci. Previous work often clustered
ESTs/mRNAs based on genomic overlap. This, however,
could accidentally cluster neighboring genes into one.
An additional confounding factor is that many genes
in higher organisms are alternatively spliced. All these
aspects indicated the need for a new and accurate identi-
ﬁcation pipeline of trans-SAs.
Our trans-SA identiﬁcation pipeline was summarized
in Supplementary Figure S1 and described below. We
ﬁrst downloaded from NATsDB (4) all EST/mRNA
sequences which were (i) mapped unambiguously to the
genome and (ii) had corrected orientations. For quality
control, NATsDB applied stringent criteria to ﬁlter
ESTs/mRNAs by aligning ESTs/mRNAs to genome, ﬁl-
tering low-quality mapping, selecting best unique mapping
and inferring the correct orientation of ESTs/mRNAs
(4,5). By comparing with human full-length cDNAs
in the H-Invitational database (23), we found that our
procedure inferred the correct orientation for 186219
(or 99.5%) out of the 187156 transcripts in the database,
achieving an accuracy similar to other reports (2,24).
In the next step, our trans-SA identiﬁcation pipeline
reﬁned exon/intron boundaries. BLAT cannot always
ensure precise genome mapping for low-quality ESTs,
resulting in some ambiguous exon boundaries (25). Our
pipeline reﬁned exon boundaries by integrating multiple
evidence including standard splicing sites (GT-AG),
sequence type (mRNA or EST), boundary frequency
and chromosomal mapping quality: (i) If one boundary
encoded a standard splicing site whereas another did not,
the former was selected as the correct boundary. (ii) If the
ﬁrst criterion did not apply, the boundary inferred from
mRNAs was used in preference to that from ESTs. Our
pipeline also allowed users to manually rank their input
sequences and boundaries according to their own estimate
of quality. (iii) If the second criterion also failed, for
instance, if all input sequences were ESTs and the user
did not provide any ranking, the correct boundary was
selected to be the one which occurred most
frequently among the input sequences. (iv) If two bound-
aries occurred with the same frequency, the correct bound-
ary was deﬁned as the one inferred from the sequence with
higher mapping identity.
A gene may encode multiple transcripts due to alterna-
tive splicing and a transcript may correspond to multiple
ESTs due to redundant sequencing. Thus, following
Riken’s deﬁnition, we grouped ESTs/mRNAs into tran-
scripts and clustered alternatively spliced transcripts into
one transcriptional unit (TU), if the ESTs/mRNAs shared
exonic overlap of at least one nucleotide and had the same
chromosomal orientation. Grouping ESTs/mRNAs into
TUs was advantageous over previous pipelines that
grouped them into genomic clusters (2,3,5) or ‘transcrip-
tional forests’ (26) because a cluster or a transcriptional
forest may accidentally include multiple TUs because of
the existence of hundreds of triplet and quadruplet cases
of cis-SAs that we had previously discovered (5).
We used the Splicing Variant Analysis Platform (SVAP)
(http://svap.cbi.pku.edu.cn) to assemble ESTs/mRNAs
into alternatively spliced transcripts using splice graphs.
Similar to existing variant ﬁnders such as ASPIC (27)
and ESTGene (28), SVAP represented a splice graph as
a directed acyclic graph (DAG), using nodes to represent
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SVAP walked through all possible paths of the splicing
DAG and created a variant for each path. To ﬁlter out
possible false positives, SVAP discarded those variants
with at least one exon that was not covered by any
sequence evidence (24).
The result of SVAP was a huge collection of isoforms
assembled into TUs, from which we then identiﬁed trans-
and cis-SAs. We ran BLASTN using the collection of
isoforms as queries against their reverse complement
sequences (by setting BLASTN parameter  S to 2).
Previous work has used two diﬀerent criteria to deﬁne
trans-SAs: (i) an e-value cutoﬀ of 10
 9 (18) and (ii) an
e-value cutoﬀ of 10
 9 with an identity threshold of 98%
(10). We chose the former criteria because the sequence
identity between the partners of two validated trans-SAs
in Lymnaea, antiNOS-1/Lym-nNOS and antiNOS-2/
Lym-nNOS, was both 80%, lower than the identity thres-
hold in the latter criteria (14). miRNAs are also known to
form imperfect base-pairing with their trans targets. If a
sequence and the reverse complement sequence of another
sequence had a pairwise BLASTN e-value lower than 10
 9
and were mapped to nonoverlapping genomic coordi-
nates, they were considered a trans-SA pair. Otherwise,
if they had overlapping genomic coordinates, they were
considered a cis-SA pair. We then condensed trans-SA
pairs into trans-SA TU pairs, which were reported and
analyzed in this manuscript.
Finally, we applied additional ﬁlters to further ensure
the high quality of the trans-SAs identiﬁed. First, we
removed trans-SAs that had any pairing regions mapped
to known repeats (deﬁned by UCSC Genome Browser)
(29). Second, we mapped the trans-SA TUs to known
pseudogenes downloaded from www.pseudogene.org
and discarded all TUs having overlapping chromosomal
coordinates with a pseudogene. Third, to avoid false TUs
resulting from incorrectly inferred transcript orientation,
we followed the strategy published by Engstrom et al. (24)
and discarded a TU if the number of transcripts mapped
to it were less than a threshold t. t was set to be the small-
est integer greater than 2 for which P(Bin(N, P) t) 0.01,
where N was the total number of ESTs/mRNAs mapped
to the TU, P was the estimated rate of misorientation
of ESTs/mRNAs (0.5% in our case) and Bin stood for
binomial distribution (24). This stringent ﬁlter oﬀered an
additional beneﬁt of eliminating possible noisy transcrip-
tion or genomic sequence contamination because these
were less likely to have large number of transcripts.
Determination of coding potential
Our pipeline for determining coding potential of a TU was
summarized in Supplementary Figure S2. We ﬁrst identi-
ﬁed protein-coding TUs based on NCBI gene annotations
(30). For unannotated TUs, we used Coding Potential
Calculator (CPC) to predict their coding potential (31).
CPC extracts six features from the transcript’s sequence
and inputs these features into a support vector machine
(SVM) classiﬁer. Using several reference databases as test-
ing datasets, the accuracy of CPC was shown to be
over 91%, outperforming other existing prediction
algorithms (31). If CPC predicted that a TU had both
noncoding RNAs and protein-coding RNAs, as some
noncoding RNAs are known to be transcribed from pro-
tein-coding genes (32), we considered this TU as protein-
coding. Only those TUs in which all RNAs were predicted
to lack coding potential were considered as noncoding.
Calculation ofhybridizing potential oftrans-SAs
by DINAMelt
DINAMelt, a RNA hybridization prediction program
(33,34), used an in silico RNA hybridization model to
predict the hybridizing regions between two RNAs and
was able to handle matched pairs, mismatches and sym-
metric and asymmetric interior loops. The thermodynamic
parameters of oligonucleotides by DINAMelt had good
agreement with experimental data (34) and it had been
successfully used in many area such as the design of
gene probes and microarray oligonucleotides and the pre-
diction of miRNA targets (35). The parameters of
DINAMelt were set as default: the concentrations of
two molecules were equal and two molecules were hybri-
dized at 378C.
Finding functionalcategories and pathways
enrichedin trans-SAs
To study the functional categories involved, we mapped
all TUs to Entrez Gene (30) and retrieved their func-
tional categorization based on Gene Ontology (GO) (36)
annotations available in Entrez Gene. We then used
GO::TermFinder (37) to ﬁnd statistically enriched GO
terms. Assuming a hypergeometric distribution, GO::
TermFinder compared the number of trans-SA TUs that
fell into each functional category against the number
of TUs in the whole genome that fell into the same
functional category and calculated a P-value for each
enriched GO term. GO::TermFinder also implemented a
1000-simulation-based correction for multiple hypotheses
testing for every P-value. The functional categories with
corrected P-value 0.01 were considered statistically
enriched in trans-SAs.
To study the pathways involved, we used the KOBAS
software (38) to assign TUs to metabolic pathways based
on sequence similarity to sequences in known pathways
in the KEGG database (39). KOBAS then compared
the number of trans-SA TUs in each pathway against
the number of all TUs in the genome in the same pathway,
assuming a hypergeometric distribution (38). To reduce
Type-1 errors, KOBAS performed an FDR correction.
Pathways with q-value 0.01 were considered to be
statistically enriched.
Analysisof expression profiles of trans-SAs
Signiﬁcant positive or negative expression correlation
could give hints on antisense RNAs’ concordant or reci-
procal regulation (40). We used the enlarged human
SAGE library consisting of 309 samples on GPL4 plat-
form, downloaded from NCBI GEO (http://www.ncbi.
nlm.nih.gov/geo/query/acc.cgi?acc¼GPL4). We recon-
structed 22 ‘tissue-type’ SAGE libraries (adrenal cortex,
blood, bone, brain, breast, colon, eye, kidney, liver,
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stomach, thyroid, pancreas, peritoneum, sciatic nerve
and sperm). After being normalized to tags per million
(tpm), only tags that could be mapped unambiguously
to TUs by SAGEMap (http://www.ncbi.nlm.nih.gov/
SAGE/) were used. The expression level of a TU in a
tissue library was set to the sum of tpm of all SAGE
tags containing the TU in that tissue library (41). Only
TUs with at least 3 tpm across all the tissues were kept
in order to eliminate potential sequencing errors in low-
abundance SAGE tags (42). We adopted the correlation
coeﬃcient r following the same strategy proposed by
RIKEN group (40). We made one important improve-
ment: we tested whether a correlation coeﬃcient r was
statistically signiﬁcantly diﬀerent from what one would
expect by chance in which the population correlation coef-
ﬁcient   was equal to zero. We calculated the P-value
using t-test. To reduce Type-1 errors, we then performed
an FDR correction (43) with a stringent cutoﬀ of
q-value 0.01.
Conservation oftrans-SAs between human and mouse
We sought to investigate whether any trans-SAs were
conserved between human and mouse. We ﬁrst mapped
TUs across species by NCBI HomoloGene (44) and
BLASTN search (5): (i) If both partners of a human
trans-SA could be mapped to partners of a mouse trans-
SA by HomoloGene, this trans-SA was considered con-
served between human and mouse. (ii) If one partner of a
human trans-SA could be mapped to a partner of a mouse
trans-SA by HomoloGene but the other partner could not,
we calculated the sequence similarity between the unmap-
ped partners using pair-wise BLASTN. If BLASTN
e-value<10
 10, identity>80% and alignment length
>100nt (5), we considered this trans-SA pair to be con-
served between human and mouse. (iii) For the remain-
ing human trans-SAs with neither partner mapped by
HomoloGene, we performed all-against-all BLASTN
search against mouse trans-SAs. A trans-SA was
considered conserved between human and mouse if both
partners passed the above BLASTN similarity cutoﬀ.
We next considered a second evidence of conserva-
tion, complementary to the ﬁrst one, by human-mouse
BLASTZ genome alignment that identiﬁed homologous
regions of the human and mouse genomes by alignment
of large neutrally evolving regions, allowing nucleo-
tide substitutions (45). We extracted the borders for all
human TUs involved in trans-SAs and identiﬁed their
homologous genomic regions in mouse, using the
human-mouse BLASTZ CHAIN pair-wise alignment
from the UCSC Genome Browser Database (assembly
hg18, mm8) (29). We chose the CHAIN alignment because
it permitted a region of the human genome to be aligned
to more than one region in the mouse genome (46). If the
genomic regions of a human trans-SA and a mouse
trans-SA were homologous, the trans-SA was considered
conserved between human and mouse.
RESULTS
A new pipeline identified trans-SAs in 10 species
Using the new pipeline, we identiﬁed trans-SAs in human
and nine other animal species. Table 1 showed the number
and percentage of trans-SAs identiﬁed. The percentage of
TUs involved in trans-SAs among all TUs was as high
as 4.13%. In particular, in human, we found that 2896
TUs (or 2.89% of all human TUs) were involved in
3327 trans-SAs (sometimes one TU may be involved in
two or more trans-SAs). Our results showed that the
number of human trans-SAs had previously been severely
underestimated. Lehner et al. (18) and Li et al. (10) iden-
tiﬁed 92 and 161 human trans-SAs on the transcript level,
respectively, whereas we identiﬁed thousands on the
TU level. As another example, in mouse, we found that
1519 TUs (or 3.13%) were involved in trans-SAs. The
chromosomal distribution of TUs involved in human
trans-SAs could be viewed at http://trans.cbi.pku.edu.cn/
html/trans_overview.php?spe¼hs. A segment on human
chromosome 10 was illustrated in Figure 1.
Table 1. Input and output statistics of trans-SAs in 10 species
Species GoldenPath
genome version
Number of
orientation-reliable
sequences mapped to
exact genomic location
from NATsDB
Total number
of TUs
Number of
trans-SA TU
pairs
Number of TUs
involved in trans-SAs
b
Proportion of TUs
involved in trans-SAs
among all TUs (%)
Human hg18 4494665 99919 3327 2896 2.89
Mouse mm8 2100305 57416 1519 1799 3.13
Fly dm2 310319 15375 76 122 0.79
Worm ce2 291395 19815 41 69 0.35
Sea squirt ci2 414454 14273 1216 589 4.13
Rat
a rn4 463787 40428 110 188 0.47
Cattle
a bosTau2 536939 27102 251 302 1.11
Dog
a canFam2 203772 16956 31 54 0.32
Chicken
a galGal2 299931 21426 37 66 0.31
Zebraﬁsh
a danRer4 522259 23809 185 282 1.18
aDue to the relatively small amount of available ESTs compared to their genome size for these species, the absolute numbers reported for these ﬁve
species may be low and the percentages may not be accurate. However, the candidate trans-SAs identiﬁed should still be reliable.
bPrevious papers reported the number and percentages of genes forming cis-SAs in terms of clusters or transcriptional forests. Here, we reported the
number and percentage in terms of TUs.
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(http://www.mysql.com/) relational database and devel-
oped a web interface of the database using PHP (http://
www.php.net/) and GD (http://www.boutell.com/gd/)
graphical libraries. The database, named Trans-SAMap,
is freely available at http://trans.cbi.pku.edu.cn/. Users
could interactively browse the database or search the data-
base by TUs, Entrez Gene synonyms (44), mRNA/EST
accession numbers, chromosomal locations and sequences
(by BLAST similarities). Each trans-SA was displayed
graphically, showing the overlapping patterns and other
annotations.
One-fourth ofhuman trans-SAs involved noncodingRNAs
We next examined whether and how many human trans-
SAs involved noncoding TUs. We classiﬁed trans-SAs
into three types: protein-coding–protein-coding pairs
(p–p pairs), noncoding–protein-coding pairs (n–p pairs)
and noncoding–noncoding pairs (n–n pairs). In human,
332 noncoding TUs were involved in 830 trans-SAs
(24.9% of all human trans-SAs), including 753 n–p pairs
and 77 n–n pairs. On average, each noncoding TU was
involved in 2.5 trans-SAs, indicating that some noncoding
RNAs might not only have trans-antisense activities but
might also potentially regulate multiple targets.
In 247 human n–p pairs, the protein-coding TU had
coding regions (CDS) annotation. Among them, in 172
(69.6%) pairs, the partner noncoding TU overlapped
with CDS of the protein-coding TU, 46 (18.6%) with
30 UTR and 29 (11.8%) with 50 UTR. Diﬀerent
locations of the overlapping in trans-SAs may be related
to diﬀerent regulatory mechanisms (1,10). Overlapping
with CDS of a sense transcript may destroy the sense
transcript through an RNA interference (RNAi) mechan-
ism (18) or interfere with the sense transcript’s interaction
with their trans-acting proteins; an overlap in the 30UTR
might aﬀect the sense-mRNA’s stability in cytoplasm (47)
or its transport out of the nucleus (1) and an overlap in the
50UTR might regulate mRNA translation initiation in
a manner similar to, for example, what occurs with
RNA III (48).
Trans-SAs may formsophisticated RNA–RNA
pairing patterns
We observed that trans-SAs had diverse sequence comple-
mentary patterns, which may relate to their being involved
in diﬀerent regulatory mechanisms. Particularly, for many
trans-SAs, there was more than one region that was com-
plementary between two transcripts. Based on diﬀerent
patterns of BLASTN High-Scoring Pairs (HSPs) in a
trans-SA, we constructed a new classiﬁcation schema con-
sisting of four classes of trans-SAs, shown in Figure 2A
and described below:
(i) ‘Single’: both transcripts contain only one HSP.
(ii) ‘Optional’: one transcript contains a region that
can form HSPs with more than one distinct region
in the paired transcript
(iii) ‘Parallel’: both transcripts contain more than one
HSP, forming pairing regions in parallel.
(iv) ‘Mixed’: a pair of trans-SA transcripts with other,
often more complicated, pairing patterns that
cannot be classiﬁed into any of the above three
classes. This class included transcripts that had simul-
taneously two or more of the above pairing patterns
of HSPs (e.g. Figure 2A ‘Mixed’ which is a mixture of
‘Optional’ and ‘Parallel’) as well as transcripts in
which the HSPs overlap in their sequence coordinates.
We observed that although the ‘Single’ class was pre-
dominant, a signiﬁcant number of trans-SAs fell into the
‘Optional’, ‘Parallel’ and ‘Mixed’ classes (Figure 2B).
The number of pairs with a perfect sequence match and
the median length of the overlapping region were listed
in Supplementary Table S1. Most trans-SA overlapping
regions were longer than 50 bps, which was clearly diﬀer-
ent from those of small trans-acting RNAs such as
miRNAs. The majority of the pairings were imperfect,
which was reasonable because, unlike cis-SAs, two part-
ners of a trans-SA were transcribed from diﬀerent
chromosomal loci and small trans-acting RNAs such as
miRNAs were known to have imperfect matches with
their targets.
We further investigated whether two transcripts in
a trans-SA could in fact bind to each other based on
the melting proﬁles calculated by DINAMelt (33,34).
The HSPs in 89.42% of trans-SAs in the ‘Single’ class
were covered by the hybridizing regions predicted by
DINAMelt, indicating that, in addition to being comple-
mentary in sequence, they were likely to hybridize in solu-
tion. Investigating the other classes, we applied two
criteria: a nonstringent one that speciﬁed that as long as
any HSP was covered by the hybridizing regions predicted
Figure 1. Trans-SAs within a segment on human chromosome 10. Arcs linking two partners of a trans-SA pair were color-coded: red arc linked
protein-coding–protein-coding pairs; blue arc linked noncoding–protein-coding pairs and green linked noncoding–noncoding pairs. In particular,
a noncoding TU, AA187228, could pair with a coding TU (RP11-564C4.1) as well as a noncoding TU (DN831175).
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dsRNA in solution and a stringent one that required that
all HSP regions in both transcripts must be covered by the
DINAMelt-predicted pairing regions. If a trans-SA pair
satisﬁed the stringent criteria, then it was more likely
that a complex pairing pattern indeed occurred in solu-
tion. Applying the nonstringent criteria, we found that
93.81% of the pairs in the ‘Optional’ class, 98.10% in
‘Parallel’ and 96.71% in ‘Mixed’ had at least one HSP
covered by the hybridization regions predicted by
DINAMelt, indicating that they may form dsRNA.
Applying the more stringent criteria, we found that
44.62% of the pairs in the ‘Optional’ class, 19.43% in
‘Parallel’ and 74.45% in ‘Mixed’ had all HSPs in both
transcripts covered by the hybridizing regions predicted
by DINAMelt, indicating that complex pairing patterns
might indeed occur.
TUs intrans-SAs were significantly enriched in nucleic
acid binding, ion/protein binding and transporter/signal
transducer functions and pathways
As shown in Supplementary Table S2 and S3, TUs in trans-
SAs were enriched in functional categories and pathways
Figure 2. Trans-SAs may have complex pairing patterns. (A) Trans-SAs are classiﬁed into four classes based on their HSP patterns. Grey blocks
indicate exons. Folding lines between blocks indicate splicing junctions. Red, blue, yellow and green blocks indicate complementary regions. (B) The
abundance of four classes of trans-SAs in 10 species.
4838 Nucleic Acids Research, 2008, Vol. 36, No. 15involved in nucleic acid binding, similar to the functional
bias of cis-SAs (5). In addition, TUs in trans-SAs were also
more common in ion/protein binding and transporter
activities as represented by the GO categories ‘ion binding’,
‘ion transport’, ‘protein binding’, ‘protein transport’,
‘membrane-bound organelle’ and ‘voltage-gated sodium
channel complex’ and by the KEGG pathways ‘Protein
export’, ‘Adhesion junction’ and ‘Tight junction’. These
were categories in which cis-SAs were not commonly
found. Enriched functions that were consistent between
human and mouse were shown in Table 2.
Our study revealed, for the ﬁrst time, the statistical
functional bias of trans-SAs in animals. Results were in
agreement with those from the small number of previous
experimental studies of individual trans-SAs in prokary-
otes and plants. For instance, in Escherichia coli, RyhB,
a 90nt noncoding RNA, is found to down-regulate a
group of iron-storage and iron-using proteins by trans-
acting when iron is limited (49); MicF gene encodes a
93nt noncoding antisense RNA and regulates target
ompF expression via a trans-pairing mechanism that inhi-
bits translation and induces mRNA degradation, thereby
aﬀecting stress response cellular processes (50). In plants,
transcripts involved in trans-SAs were found to be over-
represented in function categories such as signal trans-
ducer activity and transporter activity (19).
Some trans-SAs showed significant concordant
(positively correlated) or reciprocal (negatively
correlated) expression patterns
Signiﬁcant positive or negative expression correla-
tion between trans-SAs could suggest antisense RNAs’
concordant or reciprocal regulation. Among 392 trans-
SAs that co-occurred in at least 3 tissues and were used
in subsequent expression analysis, 164 (or 42%) showed
signiﬁcant expression correlation. Three pairs, including
two p–p pairs (ZNF227 versus CR593740, HIST1H2BG
versus HIST1H2AK) and one n–p pair (CN480497 versus
CYP4A11), showed a signiﬁcant negative expression cor-
relation (q-value 0.01), whereas remarkably, 161 pairs,
including 146 p–p pairs and 15 n–p pairs, showed a signif-
icant positive expressional correlation (q-value 0.01).
Sometrans-SAs were conservedbetween human andmouse
Our multi-species dataset enabled us to identify how
many trans-SAs were conserved between human and
mouse. Among trans-SAs where both partners had one-
to-one mapping by HomoloGene (496 in human and 321
in mouse by orthologous mapping), ﬁve p–p trans-SAs in
human (1.0%) were conserved in mouse (Table 3, panel
A). To test whether the percentage of conserved trans-SAs
diﬀered from what one would expect by chance, we
extracted all human and mouse genes in HomoloGene
and constructed 9600 pseudo human SAs and 10254
pseudo mouse SAs by pairing one gene to another ran-
domly without repetition. No pseudo human SA pairs
were found to be conserved in mouse. Fisher test con-
ﬁrmed that the fraction of conserved trans-SAs signiﬁ-
cantly diﬀered from what would be expected by chance
(P-value  2.94e-7). Among trans-SAs where one partner
was mapped to HomoloGene and the other was mapped
by BLASTN similarity (1801 pairs in human and 832 in
mouse), an additional four p–p and two n–p trans-SAs
in human were conserved in mouse (Table 3, panel B).
Table 2. Enriched Gene Ontology (GO) categories in trans-SAs that were consistent between human and mouse (corrected P-value 0.01, up to
GO level 4)
Biological Process Molecular function Cellular component
Regulation of cellular process Metal ion binding Intracellular
Transcription Cation binding Intracellular organelle
Transport DNA binding Intracellular part
Organelle organization and biogenesis Purine nucleotide binding Intracellular organelle part
DNA packaging RNA binding Cytoplasm
Cellular localization Hydrolase activity, acting on acid anhydride Membrane
Intracellular transport Cytoskeletal protein binding Cytoplasmic part
Negative regulation of biological process Transferase activity, transferring
phosphorus-containing group
Membrane part
Positive regulation of biological process Ligase activity, forming carbon–nitrogen bond Cytoskeletal part
Negative regulation of cellular process Unfolded protein binding Plasma membrane
Protein transport Ribonucleoprotein complex
Ion transport Nuclear part
Positive regulation of cellular process Organelle lumen
Regulation of cell cycle Nuclear lumen
Vesicle-mediated transport Chromosomal part
Organ development Membrane fraction
Response to DNA damage stimulus Nucleosome
Cytoplasm organization and biogenesis Cell fraction
Organelle membrane
Mitochondrial membrane
Voltage-gated sodium channel complex
Endomembrane system
Organelle inner membrane
Transcription factor complex
The detailed P-values were listed in Supplementary Table S2.
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were not covered in HomoloGene but mapped by
BLASTN similarity (1030 pairs in human and 366 in
mouse), another twelve human trans-SAs were conserved
in mouse (7 conserved p–p pairs and 5 n–p pairs, shown in
Table 3, panel C).
Two thousand ﬁve hundred and ﬁfty six human trans-
SAs could be mapped to mouse using BLASTZ alignment
as genome-based evidence of conservation. Among them,
1017 (39.7%) formed trans-SAs in mouse and were con-
sidered conserved between human and mouse
(Supplementary Table S4), including 826 p–p pairs, 188
n–p pairs and 3 n–n pairs. We shuﬄed the human and
mouse trans-SAs and constructed equal number of
human and mouse pseudo trans-SAs. Only 125 out of
2443 pseudo human trans-SAs were found to be conserved
in mouse following the same protocol. Fisher test con-
ﬁrmed that the fraction of the conserved trans-SAs we
detected was signiﬁcantly higher than what would be
expected by chance in the pseudo dataset (P-
value<2.2e-16). These results demonstrated that the con-
served trans-SAs we observed were unlikely a chance event
and suggested that they might have important functions.
A proposedmechanism of origination of some trans-SAs
via cis-SAs and geneduplication
Comparing trans-SAs and cis-SAs in human, we found
that 616 TUs involved in trans-SAs also had cis-SA
partners. Based on information in GeneCards (51), we
found that, for 30 such TUs, their cis-SA partner and
trans-SA partner were members of the same gene family
(Supplementary Table S5). Given the high abundance of
cis-SAs and the relative simplicity with which cis-SAs can
originate (52,53), it was more likely that in these dual
cases, cis-SAs originated prior to trans-SAs. The following
example illustrated one possible scenario of trans-SA ori-
gination. Human MYH11 (myosin, heavy polypeptide 11)
and MYH9 (myosin, heavy polypeptide 9) are paralogs
from the same family (based on GeneCards (51)) encoded
at separate chromosomal loci. A third gene, NDE1 (nudE
nuclear distribution gene E homolog 1), formed a cis-SA
pair with MYH11 through a polyA-sharing mechanism.
This cis-SA pair appeared to have originated recently
because in both mouse and chicken, NDE1 and MYH11
were simply neighboring genes on the opposite strands
without any overlap. Due to the high sequence similarity
between MYH11 and MYH9, NDE1 forms a trans-SA
pair with MYH9 (shown in Figure 3A).
A second example involves genes duplicated by segmen-
tal duplications. The pairing regions in 500 human trans-
SAs (15% of all human trans-SAs) could be mapped to
known segmental duplication regions based on UCSC
genome browser database. For example, the RFPL (Ret
ﬁnger protein-like) gene family is known to have under-
gone a series of duplications from an ancestor containing
a RING-B30 domain (54). RFPL1 and RFPL3 are two
members of this family, and RFPL1 is believed to be the
older of the two evolutionarily (54). RFPL1S formed
a cis-SA pair with RFPL1, and on a separate genomic
locus, RFPL3S formed a cis-SA pair with RFPL3.
Table 3. List of human trans-SAs that were conserved between human
and mouse
Trans-SA Gene symbol Gene ID TU ID
Panel A
1 FER 2241 hs_27889_p.14
THOC2 57187 hs_37092_m.1
2 TUBB3 10381 hs_13578_p.3
LOC401565 401565 hs_36040_m.0
3 KCNA6 3742 hs_7160_p.0
KCNA10 3744 hs_1560_p.3
4 LOC401565 401565 hs_36040_m.0
TUBB4 10382 hs_16192_m.0
5 PPAN 55337 hs_16298_p.0
ANGPTL2 23452 hs_35783_m.3
Panel B
1 (n–p)
a GPD1L 23171 hs_23040_p.1
CA450491
b hs_7693_m.2
 
2 (n–p)
a MAFK 7975 hs_30950_p.0
DB018139
b hs_15104_p.0
 
3 TUBB2C 10383 hs_36040_p.0
MTAP 4507 hs_34800_p.2
4 H2AFJ 55766 hs_7373_p.0
MGC12935 84780 hs_29114_p.0
5 TUBA1C 84790 hs_7676_p.2
MGC16703 113691 hs_22137_m.1
6 TUBA1C 84790 hs_7676_p.2
LOC730222 730222 hs_2584_m.0
Panel C
1 BX326232
b hs_11717_m.0
C14orf37 145407 hs_10399_m.0
2 (n–p)
a LOC729226 729226 hs_13114_p.0
 
LOC390616 390616 hs_4793_m.0
3 BU662546
b hs_13878_p.1
LOC390616 390616 hs_4793_m.0
4 (n–p)
b BG398362
b hs_18569_p.0
LOC400794 400794 hs_2189_m.2
 
5 CR602957
b hs_19485_m.8
C14orf37 145407 hs_10399_m.0
6 (n–p)
a LOC400794 400794 hs_2189_m.2
 
CDC27 996 hs_14521_m.10
7 (n–p)
a BQ935655
b hs_8564_p.2
LOC400794 400794 hs_2189_m.2
 
8 ADRA1B 147 hs_28453_p.0
BE535870
b hs_36406_m.0
9 BE535870
b hs_36406_m.0
DB239600
b hs_20661_m.4
10 (n–p)
a BM477121
b hs_36425_m.0
LOC400794 400794 hs_2189_m.2
 
11 LOC338739 338739 hs_5542_p.3
BG612114
b hs_30109_p.0
12 BC036362
b hs_8886_m.6
BE535870
b hs_36406_m.0
Panel A, List of human trans-SAs that were conserved in mouse
identiﬁed by cross-referencing HomoloGene. Panel B, List of human
trans-SAs that were conserved in mouse identiﬁed by HomoloGene
cross-reference of one TU and pair-wise BLAST similarity of the
other TU. Panel C, Human trans-SAs that were conserved in mouse
identiﬁed by pair-wise BLASTN similarity of both TUs.
a(n–p) indicates a trans-SA pair in which a noncoding TU pairs with a
protein-coding TU. The TUs without coding potential were marked
with asterisk. When not speciﬁed, the trans-SA pair is a protein-
coding–protein-coding (p–p) pair. We did not observe any n–n pairs
conserved between human and mouse.
bThese TUs have no NCBI GeneID or Gene name. Thus we used an
isoform to represent the TU.
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tity across their full length (54), RFPL1 and RFPL3S
constituted a trans-SA pair, while RFPL3 and RFPL1S
constituted another trans-SA pair (shown in Figure 3B).
DISCUSSION
Our pipeline had the highest coverage compared to
previous works (10,18,19) because of the use of ESTs in
addition to mRNAs. At the same time, our pipeline was
also rigorous, applying stringent quality control ﬁlters.
We identiﬁed an order-of-magnitude more trans-SAs in
human (at least 20 times higher than previous studies
(10,18)), as well as trans-SAs in nine other animal species
for the ﬁrst time, allowing new features of trans-SAs to be
revealed. For instance, we observed that trans-SAs could
potentially form more complex RNA–RNA pairing pat-
terns than previously thought (10,18).
We followed the common practice of ﬁltering out
repeats and pseudogenes in order to identify trans-SAs
that were most likely to be functional (10,18). How-
ever, although repeats were previously thought to be
genomic parasites (55) and their transcripts were major
targets of RNAi pathways (56), recent evidence has
suggested repeats’ roles in the regulation of transcription
or post-transcriptional events (57–59). Some repeats were
found to be under strong selective constraint (55). Some
were found to function as antisense (60,61). Similarly,
pseudogenes were often considered evolutionary ‘dead-
ends’ and ﬁltered out. However, recently a large number
of novel endogenous siRNAs were reported to be derived
from a protein-coding gene and a cis-antisense transcript
of its pseudogene, indicating the functional role of
pseudogene (or at least its cis-antisense) in regulating the
parental mRNA’s level (62,63). Interestingly, we found
that, if we had not ﬁltered out repeats and pseudogenes
in our pipeline, the ﬁnal set of trans-SAs would be 20 times
larger. The potential functions of trans-SAs involving
repeats and pseudogenes are currently under further
investigation.
Our results indicated that long noncoding RNAs, aside
from functioning as cis-antisense transcripts such as Air
(21) and Xist (20), might also function via a trans-acting
mechanism in animals and could regulate more than
one target. It was previously known that DsrA,a n8 7 n t
noncoding RNA in Escherichia coli, regulates at least ﬁve
diﬀerent genes via trans-acting RNA–RNA interaction by
diﬀerent pairing regions (64). Therefore, a trans-acting
mechanism for noncoding RNAs appeared to be capable
Figure 3. Some trans-SAs were related to cis-SAs through paralogues. (A) NDE1 and MYH11 formed a cis-SA pair sharing the last exon of NDE1
(99bp overlap with perfect complementarity), from UCSC genome browser. The arrow indicates MYH9’s paralogous exon to the cis-pairing region
of MYH11. NDE1 shares this paralogous exon and thus trans-pairs with MYH9.( B) RFPL1 and RFPL1S formed a cis-SA (293 bp overlap with
perfect complementarity). RFPL3 and RFPL3S formed another cis-SA (588 bp overlap with perfect complementarity). RFPL3S and RFPL1 formed
a trans-SA (591 bp overlap with an e-value of 0.0 and an identity of 95%). RFPL3 and RFPL1S formed another trans-SA (519 bp overlap with an
e-value of 0.0 and an identity of 96%). Red arrows indicate the cis-pairing region of RFPL1 and RFPL1S was duplicated to the locus of RFPL3
and RFPL3S.
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in which a noncoding RNA could regulate only one target
at the same genomic locus on the opposite strand. This is
reminiscent of the diﬀerence between short trans-SAs,
i.e. miRNAs, which can regulate multiple targets at diﬀer-
ent genomic loci, and siRNAs, which most often regulate
one target at the same genomic locus.
The expression proﬁles of trans-SAs pointed toward
a complexity of regulatory interactions. Well-known
short trans-acting RNAs and their targets have been
shown to have diﬀerent patterns of expression correlation.
miRNAs could act through at least two mechanisms:
imperfect base-pairing within 30UTR that blocks transla-
tion, which does not aﬀect target mRNA’s abundance, or
perfect base-pairing with miRNA-mediate cleavage and
inactivation of target mRNA, which results in a decrease
of target mRNA’s abundance (65). Data have shown that
the long trans-acting RNA, DsrA, has opposite expression
eﬀects on two diﬀerent targets both mediated by RNA–
RNA interaction: it decreases H-NS mRNA level but
increases RpoS mRNA level (64). Among 392 trans-SAs
having expression data in human tissues, we identiﬁed 164
trans-SAs that had signiﬁcant expression correlations that
might be involved in inhibition or stabilization eﬀect
of antisense transcripts. As for the remaining trans-SA
transcripts, they might be implicated in other aspects of
RNA function such as translation, RNA editing, traﬃck-
ing and subcellular localization.
We used the large human SAGE library consisting
of 309 samples on GPL4 platform for our expression stu-
dies. Admittedly this SAGE data set was still far from
complete because it provided enough data for only 12%
of all human trans-SAs. Thus, it would be important to
continue to use high-throughout technologies to further
investigate trans-SAs’ expression proﬁles. Nevertheless,
we were able to ﬁnd a remarkable 161 trans-SA pairs
with positive expression correlation. Positive expression
correlation of trans-SAs could be caused by three pos-
sible mechanisms. The ﬁrst was a dsRNA-mediated stabi-
lization function (66,67). Scheele et al. observed that a
mammalian noncoding antisense molecule (ncNAT)
could increase the abundance of its cis- target mRNA
(svPINK1) in a ‘tail-tail’ overlapping pattern (67). In the
overlapping region we detected neither AU-rich elements
(AREs) nor other rapid decay-associated motifs using
UTRscan (68) and theorized a possible mechanism: the
‘tail-tail’ overlap might aﬀect mRNA stability by reducing
mRNA decay where transcripts undergo 30!50 exonucleo-
lytic decay subsequent to poly(A) shortening (47,69). This
mechanism could potentially account for some of the posi-
tively-correlated trans-SAs. Among trans-SAs where at
least one partner had CDS annotation, 15 p–p pairs over-
lapped at 30UTR and two n–p pairs overlapped at 30UTR.
A second possible mechanism was that trans-antisense
might interrupt target intramolecular base-pairing (13)
and thereby stabilize target mRNA. For example, in
Escherichia coli, DsrA pairing stabilizes RpoS mRNA
and stimulates RpoS translation, freeing the translation
initiation region from intramolecular base-pairing and
allowing increased translation and mRNA stability (70).
The third mechanism was that trans-antisense might
function as a transcription activator (48). In
Staphylococcus aureus, aside from being an activator of
translation, RNAIII acts on the initiation of transcription
of virulence genes by means of intermediary protein fac-
tors (71). Similarly, some trans-antisense RNAs in animals
might also initiate transcription of their target genes.
We performed several analyses on the evolutionary
conservation of trans-SAs between human and mouse
and provided evidence for trans-SAs’ conservation. We
observed that, as a group, trans-SAs were signiﬁcantly
more conserved between human and mouse than what
would be expected by chance. However, the lack of
detected conservation of many trans-SAs did not neces-
sarily mean that they were not functional. First, the
ENCODE project recently reported that as many as
50% of the experimentally identiﬁed functional elements
do not show evidence of evolutionary constraint across
mammals, especially for many types of noncoding func-
tional elements (72). Second, TUs in some trans-SAs
might be under rapid sequence evolution. As widely
known, a subset of human protein-coding genes are fast
evolving, driven by positive Darwinian selection, such as
genes involved in immune response and reproduction (73).
Some functional noncoding RNAs were also found to be
subject to positive selection when associated with pheno-
typic radiation (74). Third, some pairs might be species-
speciﬁc and arose recently after the divergence of human
and mouse.
The mechanism of trans-SA origination was not studied
before. Gene duplication including segmental duplication
may contribute to trans-SA origination. Segmental dupli-
cation is known to play fundamental roles in both gene
evolution and genomic disease (75). The pairing regions in
500 human trans-SAs (15% of all human trans-SAs) could
be mapped to known segmental duplication regions
(accounting for 2% of all human segmental duplications).
The majority (85%) of human trans-SAs were not related
to segmental duplications
In summary, our comprehensive analysis oﬀers not only
candidates for further experiments but also important
clues to the function and evolution of trans-SAs in multi-
ple animal species.
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